3rd EGHRIN Seminar: Unpacking the Global Health Side Effects of the EU's Pharmaceutical Legislation Reform

Date: December 5, 2023
Time: 14:00 - 15:00 CET
Location: Online (Zoom)

The European Global Health Research Institutes Network (EGHRIN) is pleased to invite you to the 3rd seminar in our series, where we’ll discuss the far-reaching implications of the EU's pharmaceutical legislation reform on global health.

About the Seminar

As the EU progresses with ambitious pharmaceutical legislation reforms aimed at updating regulatory frameworks and ensuring timely access to medicines, it is essential to assess the potential ripple effects on global health. This seminar will delve into how these changes might impact global health equity, the accessibility of essential medicines, and policies affecting low- and middle-income countries.

Join our expert panelists for a discussion on these critical issues:

  • Astrid Berner-Rodoreda (Moderator) – Heidelberg Institute of Global Health

  • Katrina Perehudoff – Law Centre for Health and Life, University of Amsterdam

  • Carlos Durán Salinas – UMC Utrecht

  • Fatima Suleman – WHO Collaborating Centre for Pharmaceutical Policy and Evidence-Based Practice

These leading voices in global health and policy will explore:

  • The consequences of the EU's pharmaceutical reforms on worldwide medicine accessibility

  • The role of the EU in promoting health equity and supporting access to medicines in low- and middle-income countries

  • Key policy shifts needed to align the reform with global health objectives

Who Should Attend? This seminar is ideal for professionals and students in the fields of public health, global health policy, pharmaceutical regulation, international development, and anyone interested in understanding the global health implications of European policy decisions.

Register Now
Secure your spot for this insightful session! Click here to register. Registration is free and open to everyone

Don't miss this opportunity to gain a deeper understanding of how EU pharmaceutical reforms may shape the future of global health.

Next
Next

New Executive Committee chair, Jolene Skordis, presents her vision for EGHRIN